← Patent-cliff monitor small molecule MIEBO PERFLUOROHEXYLOCTANE
Loss of exclusivity June 2037 latest FDA-listed patent expiry
Company BAUSCH AND LOMB INC
Drug detail Brand name MIEBO Active ingredient PERFLUOROHEXYLOCTANE Strength 1.338GM/ML Dosage form SOLUTION/DROPS Route OPHTHALMIC Modality Small molecule FDA approval May 2023 Marketing status RX
Listed patents Patent Expires Type RE50060 June 2037 use U-4586 10682315 September 2036 use U-4586 11357738 September 2036 product 12128010 September 2036 product 10576154 October 2035 use U-1900 10369117 September 2033 use U-1900 10449164 September 2033 use U-1900 10058615 September 2033 use U-1900 12005033 September 2033 use U-4586
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.